Acrivon Therapeutics
MA - Watertown
BiotechnologyFocus: Checkpoint Inhibitor
Acrivon Therapeutics is a life sciences company focused on Checkpoint Inhibitor.
Oncology
Open Jobs
3
Pipeline & Clinical Trials
ACR-2316
Specific Advanced Solid TumorsClinical Trials (1)
NCT06667141Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
Phase 1Gemcitabine
Head and Neck Squamous Cell CarcinomaClinical Trials (1)
NCT06597565A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
Phase 2ACR-368
Endometrial AdenocarcinomaClinical Trials (1)
NCT05548296A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Phase 2Open Jobs (3)
Interview Prep Quick Facts
Portfolio: 3 clinical trials
Open Roles: 3 active jobs
Hiring Trend
Stable
3
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles